GLP-1s sometimes cause unpleasant side effects that can lead to nonadherence and discontinuation, but some patients stay the ...

A first-in-human trial shows the feasibility and safety of delivering placenta-derived stem cells during prenatal ...

About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly ...

A new AHA scientific statement warns that cardiovascular disease is rising fastest among younger women, with stroke rates in ...

An interim review finds discrimination, staffing gaps, and poor facilities continue to undermine NHS maternity care in England.

The MHRA has licensed brensocatib as the first disease-specific therapy for non-cystic fibrosis bronchiectasis in patients with recurrent exacerbations.

Despite efforts by test maker Grail to highlight outcomes the company considers positive, some experts are warning against using the Galleri test and others like it.

Walk-in appointments can reduce the time to pediatric dermatology visits for both atopic dermatitis and hidradenitis suppurativa and reduce ED visits for atopic dermatitis, a study finds.

Bimekizumab yields clinically meaningful improvements in the severity of hidradenitis suppurativa over 48 weeks, shifting most patients to a mild disease, a pooled analysis of two trials shows.

A new consensus statement from the American Society of Clinical Psychopharmacology offers guidance on when — and whether — to discontinue psychotropic medications.

Chronic kidney disease is associated with a significantly increased risk for workforce detachment among adults of working age, a Danish study finds.

Cardiovascular mortality among US adults with obesity tripled from 1999 to 2023, with persistent and widening disparities across certain sociodemographic and geographic groups.